| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocardia, Inc. (BCDA) has 9 insiders with recent SEC Form 4 filings, including 15 buys and 0 sells. BCDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 293.3K | $283.5K | - | |
| CFO | 106.2K | $102.7K | - | |
| VP | 47.0K | $45.5K | - | |
| Dir | 15.7K | $15.2K | - | |
| Dir | 15.6K | $15.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2019 | Altman Peter47 | President And CEO | Buy | 50 | $1.59 | $79.50 | - | |
| Dec 24, 2018 | Stertzer Simon H | Director | Buy | 3,333,332 | $0.75 | $2,499,999.00 | +110.1% | |
| Dec 24, 2018 | Frost Phillip Md Et Al48 | 10% Owner | Buy | 2,000,000 | $0.75 | $1,500,000.00 | +18.4% | |
| Nov 29, 2018 | Stertzer Simon H | Director | Buy | 1,000 | $2.10 | $2,102.00 | +20.0% | |
| Nov 16, 2018 | Altman Peter47 | President And CEO | Buy | 6,400 | $2.34 | $14,983.94 | +0.3% | |
| Nov 14, 2018 | Stertzer Simon H | Director | Buy | 1,000 | $2.14 | $2,140.50 | +25.0% | |
| Nov 13, 2018 | Stertzer Simon H | Director | Buy | 1,000 | $2.10 | $2,100.00 | +33.3% | |
| Nov 13, 2018 | Altman Peter47 | President And CEO | Buy | 3,900 | $2.16 | $8,411.80 | +0.3% | |
| Nov 9, 2018 | Altman Peter47 | President And CEO | Buy | 500 | $2.50 | $1,251.00 | - | |
| Nov 5, 2018 | McClung David | Chief Financial Officer | Buy | 1,600 | $2.56 | $4,102.40 | +34.8% |